Sensus Healthcare Inc (NASDAQ: SRTS) has a price-to-earnings ratio that is above its average at 14.20x. The stock has a 36-month beta value of 1.22. Opinions on the stock are mixed, with 1 analysts rating it as a “buy,” 3 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for SRTS is 13.17M, and at present, short sellers hold a 10.30% of that float. On January 31, 2025, the average trading volume of SRTS was 234.95K shares.
SRTS) stock’s latest price update
The stock of Sensus Healthcare Inc (NASDAQ: SRTS) has increased by 18.05 when compared to last closing price of 6.87. Despite this, the company has experienced a 13.59% gain in its stock price over the last five trading sessions. zacks.com reported 2025-01-28 that Sensus Healthcare, Inc. (SRTS) closed at $6.92 in the latest trading session, marking a +1.91% move from the prior day.
SRTS’s Market Performance
SRTS’s stock has risen by 13.59% in the past week, with a monthly rise of 13.11% and a quarterly rise of 16.69%. The volatility ratio for the week is 5.16% while the volatility levels for the last 30 days are 5.33% for Sensus Healthcare Inc The simple moving average for the past 20 days is 17.22% for SRTS’s stock, with a 30.00% simple moving average for the past 200 days.
Analysts’ Opinion of SRTS
Maxim Group, on the other hand, stated in their research note that they expect to see SRTS reach a price target of $14, previously predicting the price at $12. The rating they have provided for SRTS stocks is “Buy” according to the report published on November 15th, 2024.
SRTS Trading at 6.01% from the 50-Day Moving Average
After a stumble in the market that brought SRTS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -13.07% of loss for the given period.
Volatility was left at 5.33%, however, over the last 30 days, the volatility rate increased by 5.16%, as shares surge +14.38% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +3.60% upper at present.
During the last 5 trading sessions, SRTS rose by +10.85%, which changed the moving average for the period of 200-days by +147.34% in comparison to the 20-day moving average, which settled at $6.91. In addition, Sensus Healthcare Inc saw 17.20% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SRTS starting from Heinrich John, who sale 15,227 shares at the price of $6.24 back on May 20 ’24. After this action, Heinrich John now owns 59,940 shares of Sensus Healthcare Inc, valued at $95,016 using the latest closing price.
Heinrich John, the Director of Sensus Healthcare Inc, sale 4,773 shares at $5.95 during a trade that took place back on May 17 ’24, which means that Heinrich John is holding 75,167 shares at $28,399 based on the most recent closing price.
Stock Fundamentals for SRTS
Current profitability levels for the company are sitting at:
- 0.29 for the present operating margin
- 0.61 for the gross margin
The net margin for Sensus Healthcare Inc stands at 0.23. The total capital return value is set at 0.22. Equity return is now at value 18.86, with 16.87 for asset returns.
Based on Sensus Healthcare Inc (SRTS), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at 4.09. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is 49.14.
Currently, EBITDA for the company is 79000.0 with net debt to EBITDA at -1.77. When we switch over and look at the enterprise to sales, we see a ratio of 2.74. The receivables turnover for the company is 2.44for trailing twelve months and the total asset turnover is 0.69. The liquidity ratio also appears to be rather interesting for investors as it stands at 10.52.
Conclusion
To sum up, Sensus Healthcare Inc (SRTS) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
